Public Employees Retirement System of Ohio Sells 1,110 Shares of Doximity, Inc. (NASDAQ:DOCS)

Public Employees Retirement System of Ohio lowered its stake in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 2.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 44,550 shares of the company’s stock after selling 1,110 shares during the period. Public Employees Retirement System of Ohio’s holdings in Doximity were worth $1,941,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Fountainhead AM LLC bought a new stake in shares of Doximity during the third quarter valued at approximately $710,000. Penserra Capital Management LLC bought a new stake in shares of Doximity during the third quarter valued at approximately $2,384,000. Federated Hermes Inc. raised its position in shares of Doximity by 1,824.5% during the second quarter. Federated Hermes Inc. now owns 279,634 shares of the company’s stock valued at $7,821,000 after buying an additional 265,104 shares during the last quarter. AXA S.A. raised its position in shares of Doximity by 40.2% during the second quarter. AXA S.A. now owns 216,392 shares of the company’s stock valued at $6,052,000 after buying an additional 61,992 shares during the last quarter. Finally, Nisa Investment Advisors LLC raised its position in shares of Doximity by 15,714.3% during the second quarter. Nisa Investment Advisors LLC now owns 11,070 shares of the company’s stock valued at $310,000 after buying an additional 11,000 shares during the last quarter. Institutional investors own 87.19% of the company’s stock.

Doximity Trading Down 1.0 %

Shares of DOCS opened at $52.19 on Thursday. The firm has a market capitalization of $9.74 billion, a P/E ratio of 59.99, a P/E/G ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $61.75. The firm has a fifty day moving average price of $48.58 and a 200-day moving average price of $38.46.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on DOCS shares. Baird R W raised shares of Doximity to a “strong-buy” rating in a report on Tuesday, September 17th. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and raised their target price for the company from $40.00 to $60.00 in a report on Wednesday, November 13th. JPMorgan Chase & Co. raised their target price on shares of Doximity from $30.00 to $48.00 and gave the company a “neutral” rating in a report on Thursday, November 21st. Barclays raised their target price on shares of Doximity from $52.00 to $75.00 and gave the company an “overweight” rating in a report on Monday, November 11th. Finally, Wells Fargo & Company raised shares of Doximity from an “underweight” rating to an “equal weight” rating and raised their target price for the company from $19.00 to $41.00 in a report on Friday, November 8th. Twelve analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $52.44.

Read Our Latest Analysis on DOCS

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.